Next Article in Journal
Effects of Nitrogen and Tensile Direction on Stress Corrosion Cracking Susceptibility of Ni-Free FeCrMnC-Based Duplex Stainless Steels
Previous Article in Journal
Investigation of Quasi-Static Indentation Response of Inkjet Printed Sandwich Structures under Various Indenter Geometries
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessArticle
Materials 2017, 10(3), 291; doi:10.3390/ma10030291

Fabrication and Cytotoxicity of Fucoidan-Cisplatin Nanoparticles for Macrophage and Tumor Cells

1
Department of Bioscience and Biotechnology, National Taiwan Ocean University, No. 2, Beining Road, Keelung City 202, Taiwan
2
Seafood Technology Division, Council of Agriculture Fisheries Research Institute, No. 199 Hou-Ih Road, Keelung City 202, Taiwan
*
Authors to whom correspondence should be addressed.
Academic Editor: Maryam Tabrizian
Received: 26 December 2016 / Revised: 3 March 2017 / Accepted: 6 March 2017 / Published: 14 March 2017
(This article belongs to the Section Biomaterials)
View Full-Text   |   Download PDF [1238 KB, uploaded 14 March 2017]   |  

Abstract

Fucoidan, an anionic, sulfated polysaccharide from brown seaweed, is known to exhibit antitumor and immunomodulatory functions. To develop an immune protection and chemotherapeutic agent, fucoidan-cisplatin nanoparticles (FCNPs) were designed. FCNPs were prepared by mixing cisplatin with fucoidan solution or fucoidan with cisplatin solution, followed by dialysis to remove trace elements. The nanoparticles, comprising 10 mg of fucoidan and 2 mg of cisplatin, which exhibited the highest cisplatin content and loading efficiency during the production process, were named as Fu100Cis20. The cisplatin content, cisplatin loading efficiency, nanoparticle size, and zeta potential of Fu100Cis20 were 18.9% ± 2.7%, 93.3% ± 7.8%, 181.2 ± 21.0 nm, and −67.4 ± 2.3 mV, respectively. Immune protection assay revealed that Fu100Cis20-treated RAW264.7 cells were protected from the cytotoxicity of cisplatin. Furthermore, antitumor assay indicated that Fu100Cis20-treated HCT-8 cells showed stronger cytotoxicity than those treated with cisplatin alone. These results suggested that fucoidan-based nanoparticles exhibited suitable particle size and high drug encapsulation, and that Fu100Cis20 has potential application in both immunotherapy and chemotherapy. View Full-Text
Keywords: fucoidan; cisplatin; immune protection; anti-tumor activity fucoidan; cisplatin; immune protection; anti-tumor activity
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Hwang, P.-A.; Lin, X.-Z.; Kuo, K.-L.; Hsu, F.-Y. Fabrication and Cytotoxicity of Fucoidan-Cisplatin Nanoparticles for Macrophage and Tumor Cells. Materials 2017, 10, 291.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Materials EISSN 1996-1944 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top